Autoimmune markers for progression of Libby amphibole lamellar pleural thickening.
Pleural disease
ROC
asbestos
autoantibodies
cytokines
sensitivity
specificity
Journal
Inhalation toxicology
ISSN: 1091-7691
Titre abrégé: Inhal Toxicol
Pays: England
ID NLM: 8910739
Informations de publication
Date de publication:
Historique:
pubmed:
10
12
2019
medline:
27
5
2020
entrez:
10
12
2019
Statut:
ppublish
Résumé
Exposure to Libby Asbestiform Amphibole (LAA) is associated with asbestos-related diseases, including mesothelioma, pulmonary carcinoma, pleural fibrosis, and systemic autoimmune diseases. The pleural fibrosis can manifest as a rapidly progressing lamellar pleural thickening (LPT), which causes thoracic pain, dyspnea, and worsening pulmonary function tests (PFT). It is refractory to treatment and frequently fatal.
Identifiants
pubmed: 31814459
doi: 10.1080/08958378.2019.1699616
pmc: PMC7450909
mid: NIHMS1621095
doi:
Substances chimiques
Antibodies, Antinuclear
0
Asbestos, Amphibole
0
Autoantibodies
0
Biomarkers
0
Cytokines
0
Collagen
9007-34-5
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
409-419Subventions
Organisme : NCATS NIH HHS
ID : UL1 TR002319
Pays : United States
Références
Am J Ind Med. 2014 Nov;57(11):1197-206
pubmed: 24898907
Acad Radiol. 2002 Nov;9(11):1278-85
pubmed: 12449360
J Toxicol Environ Health A. 2018;81(19):1015-1027
pubmed: 30230971
Public Health Rep. 2009 May-Jun;124(3):471-4
pubmed: 19445426
Am J Ind Med. 2017 Jan;60(1):20-34
pubmed: 27859510
Pulm Med. 2011;2011:105707
pubmed: 21660282
J Exp Med. 2010 Mar 15;207(3):535-52
pubmed: 20176803
Am J Physiol Lung Cell Mol Physiol. 2016 Jun 1;310(11):L1071-7
pubmed: 27106292
N Engl J Med. 2003 Oct 16;349(16):1526-33
pubmed: 14561795
Toxicol Lett. 2012 Jan 25;208(2):168-73
pubmed: 22085844
Lupus. 2016 Jul;25(8):838-49
pubmed: 27252260
J Expo Sci Environ Epidemiol. 2015 Jan;25(1):18-25
pubmed: 24756101
Autoimmune Dis. 2014;2014:782045
pubmed: 24876951
Int J Occup Environ Health. 2010 Jul-Sep;16(3):279-90
pubmed: 20662420
J Cell Mol Med. 2014 Sep;18(9):1773-84
pubmed: 25091058
Inhal Toxicol. 2013 Dec;25(14):774-84
pubmed: 24304304
Toxicol Appl Pharmacol. 2014 Mar 15;275(3):257-64
pubmed: 24518925
Arch Intern Med. 1996 Jul 8;156(13):1421-5
pubmed: 8678710
Arthritis Rheum. 2007 Jul;56(7):2344-51
pubmed: 17599763
J Toxicol Environ Health A. 2018;81(15):734-747
pubmed: 29927712
Toxicol Appl Pharmacol. 2017 Nov 1;334:24-34
pubmed: 28870655
Arthritis Rheum. 2012 Jul;64(7):2319-27
pubmed: 22237992
Results Immunol. 2013 Nov 09;5:13-22
pubmed: 26623249
J Immunotoxicol. 2014 Jul-Sep;11(3):283-90
pubmed: 24164284
Physiol Rep. 2016 Aug;4(15):
pubmed: 27519611
Am J Ind Med. 2004 Sep;46(3):219-25
pubmed: 15307120
Lupus. 2006;15(11):737-45
pubmed: 17153844
Br J Ind Med. 1993 Oct;50(10):898-901
pubmed: 8217848
Radiology. 1982 Apr;143(1):29-36
pubmed: 7063747
J Occup Environ Med. 2018 Feb;60(2):167-173
pubmed: 29200190
Int J Hyg Environ Health. 2017 Nov;220(8):1230-1241
pubmed: 28778427
Biometrics. 1988 Sep;44(3):837-45
pubmed: 3203132
Inhal Toxicol. 2006 Nov;18(12):963-7
pubmed: 16920669